Join us on Tuesday, May 13, at 12 pm ET for a presentation of the NJ ACTS Special Populations Core 2025 Seminar Series -“Epidemiologic Challenges in Using Claims Data to Study Opioid Use Disorder Treatment Trajectories” with Danya M. Qato, PharmD, MPH, PhD.

The presentation will introduce the audience to her FDA-funded project titled ‘Data-informed Models to Identify Optimal Opioid Use Disorder (OUD) Treatment Trajectories’ and discuss specific epidemiologic challenges to using longitudinal healthcare claims data to study OUD treatment pathways, namely focused on implications of cohort, index date, and exposure definitions. Dr. Qato will also share preliminary findings from her analysis of healthcare claims data of Medicare and commercially-insured populations with OUD.

Dr. Danya Qato is an associate professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy with a secondary appointment in Epidemiology at the School of Medicine. She is a pharmacist, epidemiologist, and health services researcher whose research in improving care for older adults and those with opioid and other substance use disorders is currently or has previously been funded by the National Institute on Aging, the Food and Drug Administration, the Robert Wood Johnson Foundation, and the Institute for Clinical and Translational Research.